• EyePerformance

Glimmers of hope at the end of the tunnel for the global economy.

The month of October was quite rough for most investors as a result of the uncertain outcome of the US elections, the US fiscal stimulus package deadlock, and the announcement of new lockdowns in various European countries (Germany, France, the UK, etc.) due to the recent surge in cases of COVID-19. Despite the positive news that as of the 30th of October, 64% of the S&P 500 companies reported earnings with 86% having performed above Wall Street estimates, the market outlook for November was nothing but a large question mark for most investors.

Download PDF • 551KB

At EyePerformance, although we acknowledged the severity of the political and economic situations, we suggested in our October Market View that a somewhat gloomy scenario was already priced in equity markets and that November should bring positive (if any) surprises for investors on different fronts. And so, they came along

7 vistas0 comentarios

Entradas Recientes

Ver todo

Volatility Rules

The month of January was a friendly reminder that some of our fears are not yet over and that there is still a long way to go before the pandemic and other micro/macro imbalances are defeated. The cur

Shift in our Equity Strategies: Positive to Balanced.

As already stated in our latest monthly letter, EyePerformance’s indicators have been broadly signaling a bullish landscape since the second week of November—immediately following the US elections—whe

2021: A year for the economic recovery.

As we leave the nefarious 2020 behind and enter 2021 with the lurking legacy of the pandemic still feeding the daily headlines of worldwide newspapers, the resilience of most asset markets to the COVI